
HER2-positive breast cancer: What is it? - Mayo Clinic
2024年4月9日 · HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). This protein promotes the growth of cancer cells. In about 1 of every 5 breast cancers, the cancer cells have extra copies of the gene that makes the HER2 protein.
Cáncer de mama positivo para HER2: ¿qué es? - Mayo Clinic
2024年4月9日 · HER2 no se hacen en forma rutinaria para carcinoma in situ del conducto, excepto cuando es parte de un ensayo clínico. Cada vez que el cáncer de mama recurre o se propaga, las células cancerosas deben ser examinadas de nuevo para detectar el HER2 así como el estatus del receptor de hormonas, ya que pueden haber cambiado desde el ...
HER2 阳性乳腺癌:这是什么病? - 妙佑医疗国际
2024年4月9日 · her2 阳性乳腺癌是一种被称为人表皮生长因子受体 2(her2)的蛋白质检测呈阳性的乳腺癌。 这种蛋白质对癌细胞的生长有促进作用。 每 5 名乳腺癌患者中大约有 1 名患者的癌细胞中含有用于制造 HER2 蛋白质的额外基因拷贝。
Breast cancer types: What your type means - Mayo Clinic
2024年10月31日 · HER2 positive. Breast cancer cells that make a lot of extra HER2 protein are called HER2 positive. Targeted therapy treatments with medicine that hurts cells making too much HER2 can help control this kind of breast cancer. HER2 low. Breast cancer is called HER2 low if some of the cancer cells show signs of making extra HER2.
Vaccine study for HER2-positive breast cancer moves forward
2019年3月1日 · Trastuzumab works by activating the immune system's B cells, which look for and attack breast tumor cells with HER2 proteins on the surface. The new vaccine also stimulates another group of cells in the immune system — long-lasting T cells that remember the proteins and promote resistance to recurrence.
Trastuzumab (intravenous route) - Mayo Clinic
2025年3月1日 · Trastuzumab injection is also used in combination with cisplatin and capecitabine or 5-fluorouracil to treat HER2-overexpressing metastatic (cancer that has spread) stomach and gastroesophageal (stomach and esophagus) cancer. Trastuzumab prevents the growth of some tumors that produce extra amounts of a certain substance known as the HER2 protein.
Recurrent breast cancer - Symptoms and causes - Mayo Clinic
2024年4月19日 · If your cancer makes extra HER2 protein, drugs that target that protein can help decrease the chance of the cancer recurring. Bone-building drugs. Taking bone-building drugs reduces the risk of cancer recurring in the bones (bone metastasis) in people with an increased risk for breast cancer recurrence. Maintaining a healthy weight.
Chemotherapy for breast cancer - Mayo Clinic
2025年1月10日 · HER2-positive breast cancer; Triple-negative breast cancer; High-grade breast cancers; Cancers that have spread to the lymph nodes; Larger breast cancers; Chemotherapy as the primary treatment for advanced breast cancer. If breast cancer has spread to other parts of your body and surgery isn't an option, chemotherapy can be used as the primary ...
Invasive lobular carcinoma - Diagnosis and treatment - Mayo Clinic
2024年6月26日 · HER2 is a protein that some healthy breast cells make. Some breast cancer cells develop changes that cause them to make a lot of extra HER2. Treatments can target the cells that are making extra HER2. Invasive lobular carcinomas are less likely to make extra HER2, so they're less likely to respond to this treatment.
Hormone therapy for breast cancer - Mayo Clinic
2025年1月25日 · Overview. Hormone therapy for breast cancer is a treatment for breast cancers that are sensitive to hormones. Some forms of hormone therapy for breast cancer work by blocking hormones from attaching to receptors on cancer ce